New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality
Evaluation of New Magnetic Resonance (MR) Imaging and Spectroscopy Software
Sponsor: M.D. Anderson Cancer Center
This NA trial investigates Hematopoietic and Lymphoid Cell Neoplasm and Malignant Solid Neoplasm and is currently completed. M.D. Anderson Cancer Center leads this study, which shows 9 recorded versions since 2012 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2022 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jul 2022 — Nov 2022 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2021 — Jul 2022 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Feb 2021 — Sep 2021 [monthly]
Recruiting NA
-
Jan 2021 — Feb 2021 [monthly]
Recruiting NA
-
Aug 2020 — Jan 2021 [monthly]
Recruiting NA
-
Jul 2019 — Aug 2020 [monthly]
Recruiting NA
First recorded
Apr 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- M.D. Anderson Cancer Center
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .